ARTICLE | Company News
Ascletis, CR Pharmaceutical partner to distribute HCV drug in Beijing
June 29, 2018 6:19 PM UTC
Ascletis Pharma Inc. (Hangzhou, China) partnered with the CR Pharmaceutical Commercial Group Co. Ltd. subsidiary of China Resources Pharmaceutical Group Ltd. (Beijing, China) to develop distribution networks and end-user services in Beijing for the launch of Ganovo danoprevir. China approved the HCV NS3/4A protease inhibitor in June to treat HCV infection (see “Chinese Approval for Ascletis’ HCV Drug")...
BCIQ Target Profiles